Abstract

Efficacy and Safety of Dose-Optimized Nilotinib (NIL) in Patients (Pts) with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP): ENESTxtnd Interim Analysis

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
ENESTnd Update: Nilotinib (NIL) Vs Imatinib (IM) In Patients (pts) With Newly Diagnosed Chronic Myeloid Leukemia In Chronic Phase (CML-CP) and The Impact Of Early Molecular Response (EMR) and Sokal Risk At Diagnosis On Long-Term Outcomes
Giuseppe Saglio ... Richard A Larson
Blood | VOL. 122
Giuseppe Saglio, et. al.Giuseppe Saglio ... Richard A Larson
15 Nov 2013
Dose-Optimized Nilotinib (NIL) in Patients (Pts) with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP): Final Results from ENESTxtnd Study
Timothy P Hughes ... Jeffrey H Lipton
Blood | VOL. 126
Timothy P Hughes, et. al.Timothy P Hughes ... Jeffrey H Lipton
03 Dec 2015
Efficacy and Safety of Nilotinib (NIL) vs Imatinib (IM) in Patients (pts) With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP): Long-Term Follow-Up (f/u) of ENESTnd
Richard A Larson ... Timothy P Hughes
Blood | VOL. 124
Richard A Larson, et. al.Richard A Larson ... Timothy P Hughes
06 Dec 2014
Efficacy and Safety Results from ASCEMBL, a Multicenter, Open-Label, Phase 3 Study of Asciminib, a First-in-Class STAMP Inhibitor, vs Bosutinib (BOS) in Patients (Pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Previously Treated with ≥2 Tyrosine Kinase Inhibitors (TKIs
Andreas Hochhaus ...
Blood | VOL. 136
Andreas Hochhaus, et. al.Andreas Hochhaus ...
19 Nov 2020
View more papers

More From: Blood

Paper Title
Journal
Date
Author
Momelotinib for the treatment of myelofibrosis.
Prithviraj Bose
Blood | VOL. -
Prithviraj BosePrithviraj Bose
03 Jul 2024
Efficacy of T cell assays for the diagnosis of primary defects in cytotoxic lymphocyte exocytosis.
Samuel C.C Chiang ... Yenan T Bryceson
Blood | VOL. -
Samuel C.C Chiang, et. al.Samuel C.C Chiang ... Yenan T Bryceson
03 Jul 2024
Molecular Taxonomy of Myelodysplastic Syndromes and its Clinical Implications.
Elsa Bernard ... Elli Papaemmanuil
Blood | VOL. -
Elsa Bernard, et. al.Elsa Bernard ... Elli Papaemmanuil
03 Jul 2024
Eltrombopag plus diacerein vs. eltrombopag in patients with ITP: a multicenter, randomized, open-label, phase 2 trial.
Lu Sun ... Yu Hou
Blood | VOL. -
Lu Sun, et. al.Lu Sun ... Yu Hou
03 Jul 2024
View more papers